| 2022-04-19 | Inozyme Pharma, Inc. INZY | SVP, CFO | 27,100 0.0562% | $3.69 | $99,999 | -33.04% | ||
| 2021-10-26 | Sale | Ocugen, Inc. OCGN | Chief Financial Officer | 10,000 0.0062% | $11.07 | $110,700 | -70.38% | |
| 2021-10-15 | Sale | Ocugen, Inc. OCGN | Chief Financial Officer | 7,990 0.0047% | $9.96 | $79,580 | -67.78% | |
| 2021-08-16 | Sale | Ocugen, Inc. OCGN | Chief Financial Officer | 30,000 0.0154% | $7.22 | $216,600 | -49.5% | |
| 2021-07-15 | Sale | Ocugen, Inc. OCGN | Chief Financial Officer | 31,086 0.0165% | $6.70 | $208,276 | -34.83% | |
| 2021-06-15 | Sale | Ocugen, Inc. OCGN | Chief Financial Officer | 31,000 0.0177% | $7.00 | $217,000 | -14.54% | |
| 2021-05-14 | Sale | Ocugen, Inc. OCGN | Chief Financial Officer | 31,000 0.0148% | $8.18 | $253,673 | -23.71% | |
| 2021-04-29 | Sale | Ocugen, Inc. OCGN | Chief Financial Officer | 7,990 0.0038% | $10.98 | $87,730 | -42.47% | |
| 2019-11-22 | Ocugen, Inc. OCGN | Chief Financial Officer | 10,000 0.0357% | $0.14 | $1,400 | +16.96% | ||
| 2019-10-02 | Ocugen, Inc. OCGN | Chief Financial Officer | 10,000 0.0708% | $1.88 | $18,800 | -79.79% |